Episode 202: The MS Prodrome with Dr. Helen Tremlett

Описание: In medicine, a prodrome is a set of signs or symptoms that can appear years before the major symptoms of an illness develop. Recognizing the prodromal phase of MS could mean that, one day, someone who is highly likely to be diagnosed with multiple sclerosis could receive proactive treatment years in advance and, perhaps, never develop any MS symptoms.

Dr. Helen Tremlett, a professor, and the Canada Research Chair in Neuroepidemiology and Multiple Sclerosis at the University of British Columbia, is joining me this week to discuss how understanding the MS prodrome can fundamentally change the way that MS is diagnosed and treated.

We'll also tell you about a study that shows early treatment with high-efficacy disease-modifying therapies can significantly reduce relapse rates for people living with active secondary progressive MS.

We'll share results from a study that shows, on their first visit to a neurologist, Black people have more severe MS than White people.

We'll tell you about two Phase 3 clinical trials that have just received approval from the U.S. Food & Drug Administration.

We'll share the results of a Belgian study that analyzed the efficacy of a cannabis spray in treating MS spasticity and improving quality of life.

And we'll give you a heads-up about a new web series that features raw, unfiltered conversations about the good, bad, and messy parts of living with MS.

We have a lot to talk about! Are you ready for RealTalk MS??!